Product Design
Comparison of Oxolamine Citrate and PMO Metabolism: Theoretical Explanation of the Carcinogenicity of Oxolamine Citrate and Non-Carcinogenicity of PMO
Abstract
Examines the carcinogenicity of oxolamine citrate and contrasts with the non-carcinogenicity of PMO. Bladder carcinogenesis of oxolamine in animals is identified as related to the diethylaminoethyl group and not the 3-phenyl-1,2,4-oxadiazoyl moiety. Suggests that diethylamine, a urinary metabolite of oxolamine, may be nitrosated in vivo to the carcinogen N-nitrosodiethylamine. Rejects PMO as the source of carcinogenicity.
Fields
- Author
- Schickedantz, Paul David (Lorillard nicotine augmentation project, R&D)P. D. Schickedantz was involved in the R&D nicotine augmentation project at Lorillard Tobacco Company. (Multi-State Deposition Team - Identification of Witnesses)
- Keyword
- Carcinogenic (Cancer-causing)
- Animal testing
- Additive
- Phenyl methyl oxadiazole (PMO)Anti-tussive, decreases chronic airway inflammation
- Oxolamine citrate
- Smoke Constituent
- Nitrosamines (N-nitrosamines)
- Named Organization
- Lorillard Inc. (American cigarette manufacturer)American cigarette manufacturer
- Subject
- Cancer (Health Effects)
- additives
Document Images
Accession number 208
r0f'?. CO"WOP
L0VTcl'f.r ~=~-j L;.; ~~I..,
GV*aCrTsbora
COMPARISON OF OXOLAMINE CITRATE AND PMO METABOLISM:
Theoretical Explanation of the Carcinogenicity of
Oxolamine Citrate and Non-Carcinogenicity of PMO
'Submittied by: Dr. P. D~. Schickedantz
Report number: Date: May 30, 1973
Summary or Abstract:
From a search of the literature on 3-phenyl-5-(2-diethyl-
aminoethyl)-1,2,4-oxadiazole (oxolamine) and related compounds,
it has been concluded that the bladder carcinogenesis of
oxolamine in rats is related to the diethylaminoethyl group
and not the 3-phenyl-1,2,4-oxadiazoyl moiety. Diethylamine,
a urinary metabolite of oxolamine, may possibly be nitrosated
in vivo to N-nitrosodiethylamine, a potent carcinogen~. N-
Hydroxylated aminoethyloxadiazoles and an epoxy-substituted
oxadiazole are other possible sources of carcinogenicity
which also are not structurally possible fromiPMO1.
PDS:njw ~
. ~.
Xc: Dr. H. J. Minnemeyer ~
Dr. R. S. Marmor ~
_ C+
Library - ~

COMPARISON OF OXOLAMINE CITRATE AND PMO METABOLISM:
Theoretical Explanation of the Carcinogenicity of~
Oxolamine Citrate and Non-Carcinogenicity of PMO
The effects of relatively large doses of oxolamine
citrate, I, (50-1000mg/kg) have been variously described
ranging from causing severe bladder irritation in mice,
rats and dogs (Silvestrini, et. al., 1963) to being defi-
nitely carcinogenic in the bladders of rats and dogs
(Barron, 1963).
0
CH
N J--CH2CHZN 2 5
"-C2H5
CI T RATE
I, Oxol'amine citrate = 3-phenyl-5-(2-diethylaminoethyl)-
' 1,2,4-oxadiazole, citrate salt
Dogs whose ureters were surgically re-routed to avoid
passing urine to the bladder did not develop the irritation
when given oxolamine citrate (Silvestrini, et. al., 1963b).
Hence, the inflammatory effects appear to be caused by urinary
metabolites. Also, the inflammatory effect seems to be
associated with the in vivo formation of diethylamine. Oxol-
amine free base, as well as other 5-(2-aminoethyl)-1,2,4-
O
oxidiazoles, are cleaved exceptionally easily into secondary 0
c,D
amines and 5-vinyloxadiazoles by mild heating in aqueous base CA
(Catanese, et. al., 1963). However, of the compounds studied, V7
only those which also produced diethylamine, or other secondary
amines, in the urine were bladder irritants. A separate
study (Silvestrini, et. al., 1963a) showed that indeed

-2-
diethylamine caused bladder irritation when administered
intravenously in doses of 10 mg/kg, orally at 300 mg/kg or
when solutions as dilute as 0.001 per cent were surgically
instilled directly into the bladder. A number of other
amines behaved similarly. Other toxicity studies have
shown that diethylamine causes degenerative damage,
including necrosis, in liver and kidney (Grice, et. al.,
1971).
Experimental evidence (Catanese, et. al., 1963) makes
it seem unlikely that the bladder irritation is associated
with other oxolamine metabolites. For example, 3-phenyl-
5-vinyl-1,2,4-oxadiazole, 3-phenyl-5-ethyl-1,2,4-oxadiazole,
as well as,:.3-phenyl-5-methyl-1,2,4-oxadiazole (PMO) were
not bladder irritants when administered orally to rats in
doses of 1000 mg/kg. However, a suspected metabolite,
3-phenyl-5-(2-hydroxyethyl)-1,2,4-oxadiazole, (Silvestrini,
et. al., 1964) has not been synthesized and hence has not
been tested.
Aside from the irritative effect of diethylamine,
there is a strong possibility that the carcinogenic effect
of oxolamine is due to diethylamine. Sen et. al. (1970)
found that diethylnitrosamine, a well known carcinogen of
liver, bladder and esophagus (Weisburger and Weisburger,
1966), is formed when diethylamine and sodium nitrite are
incubated with gastric juices. This nitrosation was shown
to occur in vivo in cats and rabbits. Wolf and Wasserman -
(1972) point out that the possible hazardous formation
of carcinogenic nitrosamines from dietary nitrites and

drugs containing secondary amine groups is still in need
of more study.
In order to rationalize the peculiar lability of the
5-(2-diethylaminoethyl)-1,2,4-oxadiazoles, the following
are proposed as possible non-enzymatic pathways:
(1) ~ elimination, reminiscent of the reverse
Michael reaction (Cram and Hammond, 1959), equation 1.
0
I
H
J--CH2CH2N\CC25 H-~
(equation 1)
R
HCN2N\R
(2) Elimiraation via an allyl carbonium which is
stablized by resonance with the oxadiazole ring (R. Marmor,
personal comm.)-equation 2.
.eR
HZCH2N\
R
\
Hp
--4
R
+ HN
`R
CH=CH2
H-C H2 ----
(equation 2)

Several metabolic pathways are available for degrada-
tion of oxolamine which are not possible with PMO. Some
of the possible intermediates contain functional groups,
N-hydroxy and epoxide, which have been strongly implicated
with carcinogenic activity (Miller and Miller, 1967; Badger,
1962; Daly, et. al., 1972). Silvestrini, et. al. (1964)
believe that oxolamine metabolism involves elimination of
diethylamine to form 3-phenyl-5-vinyl-1,2,4-oxadiazole which
can then add water to form~3-phenyl-5-(2-hydroxyethyl)-
1,2,4-oxadiazole. The current theory would be that the
alcohol is formed via the epoxide, equation 3.
~0
C2H5
-HN(CZHS)2
i
N~\25
-)J&_CHZCH2NCH
N 0
NiJ--CH=CH2.
0
NJ-CH CH2 --3
(equation 3)

-5-
N-hydroxylation may take place as follows, equation 4:
J--CH2CH2N\
C2H5
enmymatic dealkylation
N 5;-'I-CHZCHZN\
C2H5
(equ.ation 4)
-0 , H
N;~'-J-CH2CHZN\ H
C2 5
.
N 0
II pH
N 0 ."C2H 5
N 0
N J-CH2CHZN 'o'0H
~H

6
Since PMO has no dialkylaminoethyl group, there is no
possibility for formation of the same irritating,or carcin-
ogenic intermediates such as were possible with oxolamine.
PMO and'oxolamine have, of course, the 3-phenyl-1,2,4-
oxadiazoyl group in common. The main argument implicating
oxolamine as a carcinogen is its uniquely labile 2-diethyl-
aminoethyl group.
The lack of any carcinogenic effect attributable to
PMO is confirmed by the results of the chronic toxicity
studies in laboratory animals performed at Hazleton Labora-
tories. These results are reported in Section~VII C of this
report.

REFERENCES
Badger, G. M., "The Chemical Basis of Carcinogenic
Activity," C. C. Thomas, Publ., Springfield, Ill., 1962,
p. 54.
Barron, C. N., "Observations on the Chronic Toxicity of
3-Phenyl-5p-Diethylaminoethyl-1,2,4-Oxadiazole in the
Rat and Dog," Exptl. Mol. Pathol. Suppl. 2, 1-27 (1963).
Catanese, B., Palazzo, G., Pozzatti, C., and Silvestrini,
B., "Toxicologic Studies on 1,2,4-Oxadiazole Derivatives:
Relationship between Chemical Structure and Bladder
Irritation," Exptl. Mol. Pathol. Suppl. 2, 28-40 (1963).
Cram, D. J. and Hammond, G. S., "Organic Chemistry,"
McGraw Hill, New York, N. Y., 1959, p. 399.
Daly, J. W., Jerina, D. M., Wilkop, B., "Arene Oxides
and the NIH Shift: The Metabolism, Toxicity and
Carcinogenicity of Aromatic Compounds,"' Experimentia,
28, 1129-1264 (1972).
Grice, H. C., Barth, M. L., Cornish, H. H., Foster, G. V.,
and Gray, R. H.., "Correlation between Serum Enzymes,
Isoenzyme Patterns and Histological Detectable Organ
Damage," Food Cosmet. Toxicol. 9(6), 847-855 (1971).
Miller, J. A. and Miller, E. C., "Activation of Carcinogenic
Aromatic Amines and Amides by N-hydroxylation In~Vivo,"
in "Carcinogenisis: A Broad Critique," Williams and Wilkins,
Baltimore, Md., 1967, pp. 397-420.
Sen, L. P., Smith, D. C., and Schwinghamer, L. "Formation
of'N-Nitrosamines from Secondary Amines and Nitrite in
Human and!Animal Gastric Juice," Food Cosmet. Toxicol. 7(4),
301-7 (1969; C. A. 72, 1316f (197U': -
Silvestrini, B., Catanese, B., Garau, A., and Pozzatti, C.,
°Toxicity Studies on 3-Phenyl-5)B-Diethylaminoethyl-1,2,4-
Oxadiazole: Vesical Irritating Activity of Diethylamine
and Other Simple Amines," Exptl. Mol. Pathol. Suppl. 2, ~
41-49 (1963a). - ©
O
Silvestrini, B., Bignami, A., Garau, A., and Pozzatti, C., ~
'Toxicity Studies of 3-Phenyl-5)3-Diethylaminoethyl-1,2,4
Oxadiazole in Mice, Rats and'Dogs." Exptl. Mol. Pathol. ~
i
2
50-64 (1963b)
Su
.
,
pp
.
Silvestrini, B., Catanese, B., Corsi, G., and Ridolfi, P.
*The Urinary Metabolites of 5-(2-Diethylaminoethyl)-3-
Phenyl-1,2,4-Oxadiazole," J. Pharm. Pharmacol. 16, 38-42 (1964).

Wolff, I. A. and Wasserman, A. E., "Nitrates, Nitrites
and!Nitrosamines,"' Science, 177, 15-19 (July 7, 1972).
Weisberber, J. H., and Weisburger, E. K.,"Chemicals as
Causes of Cancer,"Chem. Enq. News, 124-141 (Feb. 7, 1966).
